Document Detail

The ethics of drug development and promotion: the need for a wider view.
MedLine Citation:
PMID:  23047778     Owner:  NLM     Status:  In-Data-Review    
Ethical issues at the interface between the medical profession and the pharmaceutical industry have generally been approached from the vantage point of medical professionalism, with a focus on conflict of interest as the key ethical concern. Although conflicts of interest remain important, other ethical issues may be obscured unless a wider perspective is adopted. Besides medical professionalism, the ethics of the clinical therapeutic relationship, ethics of public health, and business ethics all provide additional insights.
Howard Brody
Related Documents :
24563948 - Contact with the dead, religion, and death anxiety among older mexican americans.
23914068 - Proceedings of the 2013 joint jstp/ntp satellite symposium.
24948998 - Can hospital promotional activities be more ethical?
23697818 - Psychotherapy is an ethical endeavor: balancing science and humanism in clinical practice.
1730398 - Psychiatrists and the general hospital ethics committee.
24298428 - Introduction: optical trapping and applications feature issue.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medical care     Volume:  50     ISSN:  1537-1948     ISO Abbreviation:  Med Care     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0230027     Medline TA:  Med Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  910-2     Citation Subset:  IM    
*Institute for the Medical Humanities †Department of Family Medicine, University of Texas Medical Branch, Galveston, TX.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Synthesis and photopolymerization kinetics of benzophenone sesamol one-component photoinitiator.
Next Document:  Impact of Part D Low-income Subsidies on Medication Patterns for Medicare Beneficiaries With Diabete...